Literature DB >> 2036528

The distinction of positive and negative symptoms. The failure of a two-dimensional model.

S Arndt1, R J Alliger, N C Andreasen.   

Abstract

The distinction of positive and negative symptoms in describing schizophrenic patients has become popular. It presupposes that symptoms cluster in two dimensions, fitting together not only theoretically but empirically. Factor analysis of three published studies of 93, 62 and 52 schizophrenic patients and a large pooled sample showed that more than two distinct dimensions are required to categorise symptoms in schizophrenia. This result is consistent across methods and samples, and with previous literature. The added dimensionality resulted from a splitting of the positive symptom domain into more distinct factors.

Entities:  

Mesh:

Year:  1991        PMID: 2036528     DOI: 10.1192/bjp.158.3.317

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  40 in total

Review 1.  Symptom dimensions in the course of childhood-onset schizophrenia.

Authors:  D Bunk; C Eggers; M Klapal
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

Review 2.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

3.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

4.  Symptom dimensions and outcome in schizophrenia.

Authors:  Raimo K R Salokangas
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

Review 5.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

6.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

7.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

8.  Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E).

Authors:  P M Dingemans; D H Linszen; M E Lenior; R M Smeets
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 9.  Reconsidering the Latent Structure of Negative Symptoms in Schizophrenia: A Review of Evidence Supporting the 5 Consensus Domains.

Authors:  Gregory P Strauss; Anthony O Ahmed; Jared W Young; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

10.  EEG alpha coherence and psychopathological dimensions of schizophrenia.

Authors:  John P John; Sumant Khanna; N Pradhan; C R Mukundan
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.